The Potential Impact of COVID-19 Virus on the Heart and the Circulatory System

References

• Zheng Y, Ma Y, Zhang J, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiology. 2020;43:1–2.
   Google Scholar
• Quagliariello V, Bonelli A, Caronna A, et al. SARS-CoV-2 infection and cardioncology: from cardiometabolic risk factors to outcomes in cancer patients. Cancers. 2020;12:3316. doi:10.3390/cancers12113316
   PubMed Web of Science ®Google Scholar
• Bansal M. Cardiovascular disease and COVID-19. Diabetes Metab Syndr. 2020;14:247–250.
   PubMed Web of Science ®Google Scholar
• Mishra A, Sahu K, George AA, Lal A. A review of cardiac manifestations and predictors of outcome in patients with COVID – 19. Heart Lung. 2020;49:848–852. doi:10.1016/j.hrtlng.2020.04.019
   PubMed Web of Science ®Google Scholar
• Hendren NS, Drazner M, Bozkurt B, Cooper L. Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation. 2020;141:1903–1914. doi:10.1161/CIRCULATIONAHA.120.047349
   PubMed Web of Science ®Google Scholar
• Zhu H, Rhee J, Cheng P, et al. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr Cardiol Rep. 2020;22:456.
   Web of Science ®Google Scholar
• Long B, Brady W, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38(7):1504–1507. doi:10.1016/j.ajem.2020.04.048
   PubMed Web of Science ®Google Scholar
• Liu J, Virani S, Alam M, Denktas A, Hamzeh I, Khalid U. Coronavirus disease‐19 and cardiovascular disease: a risk factor or a risk marker? Rev Med Virol. 2020;31. doi:10.1002/rmv.2172
   Web of Science ®Google Scholar
• Zhao M, Wang M, Zhang J, et al. Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomed Pharmacother. 2020;127:110230. doi:10.1016/j.biopha.2020.110230
   PubMed Web of Science ®Google Scholar
• Lazaridis C, Vlachogiannis NI, Bakogiannis C, et al. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery. Hellenic J Cardiol. 2020;61:381–395. doi:10.1016/j.hjc.2020.05.004
   Web of Science ®Google Scholar
• Talasaz A, Kakavand H, Tassell BV, et al. Cardiovascular complications of COVID-19: pharmacotherapy perspective. Cardiovasc Drugs Ther. 2020;4:1–11.
   Google Scholar
• Barison A, Aimo A, Castiglione V, et al. Cardiovascular disease and COVID-19: les liaisons dangereuses. Eur J Prev Cardiol. 2020;27:1017–1025. doi:10.1177/2047487320924501
   Web of Science ®Google Scholar
• Roberts KA, Colley L, Agbaedeng T, Ellison-Hughes G, Ross M. Vascular manifestations of COVID-19 – thromboembolism and microvascular dysfunction. Front cardiovasc med. 2020;7. doi:10.3389/fcvm.2020.598400
   Web of Science ®Google Scholar
• Sabioni L, Tibiriçá E, Lamas C, Amorim GD, Lorenzo AD. Systemic microvascular dysfunction in COVID-19. Am J Cardiovasc Dis. 2020;10(4):386–391.
   Web of Science ®Google Scholar
• Tahir F, Arif TB, Ahmed J, Malik F, Khalid M. Cardiac manifestations of coronavirus disease 2019 (COVID-19): a comprehensive review. Cureus. 2020;12:e23.
   Web of Science ®Google Scholar
• Chen Q, Xu L, Dai Y, et al. Cardiovascular manifestations in severe and critical patients with COVID‐19. Clin Cardiol. 2020;43:796–802. doi:10.1002/clc.23384
   PubMed Web of Science ®Google Scholar
• Kurz DJ, Eberli FR. Cardiovascular aspects of COVID-19. Swiss Med Wkly. 2020;150:w20417. doi:10.4414/smw.2020.20417
   Web of Science ®Google Scholar
• Cannata’ A, Watson SA, Daniel A, et al. Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis. Eur J Prev Cardiol. 2021. doi:10.1093/eurjpc/zwab119
   Web of Science ®Google Scholar
• Rali A, Ranka S, Shah Z, Sauer A. Mechanisms of myocardial injury in coronavirus disease 2019. Cardiac Failure Rev. 2020;6. doi:10.15420/cfr.2020.10
   Google Scholar
• Basso C, Leone O, Rizzo S, et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J. 2020;41(39):3827–3835. doi:10.1093/eurheartj/ehaa664
   PubMed Web of Science ®Google Scholar
• Shi S, Qin M, Cai Y, et al. Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019. Eur Heart J. 2020;41(22):2070–2079. doi:10.1093/eurheartj/ehaa408
   PubMed Web of Science ®Google Scholar
• Money JE, Sekaran N, Minder CM, et al. Myocardial infarction associated with regional myocardial flow deficit and normal coronary arteries in a patient with COVID-19: a case report. Cardiol Cardiovasc Med. 2020;04(06). doi:10.26502/fccm.92920167
   Google Scholar
• Azanza DX, Ibargüengoitia MC, Uvera SR. Cardiac computed tomography as an alternative technique in the assessment of acute myocardial ischemia in the context of COVID-19 infection. Cureus. 2020;12:e23.
   Web of Science ®Google Scholar
• Shchedrygina A, Nagel E, Puntmann V, Valbuena-Lopez S. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. 2020;19:5–14. doi:10.1080/14779072.2021.1844005
   Web of Science ®Google Scholar
• Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: current problems. Intern Emerg Med. 2021;1–7. doi:10.1007/s11739-020-02494-x
   Web of Science ®Google Scholar
• Inciardi R, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA cardiol. 2020;5(7):819. doi:10.1001/jamacardio.2020.1096
   PubMed Web of Science ®Google Scholar
• Coyle J, Igbinomwanhia E, Sánchez-Nadales A, Danciu S, Chu C, Shah N. A recovered case of COVID-19 myocarditis and ARDS treated with corticosteroids, tocilizumab, and experimental AT-001. Jacc Case Rep. 2020;2:1331–1336. doi:10.1016/j.jaccas.2020.04.025
   Google Scholar
• Ho JS, Sia C, Chan M, Lin W, Wong R. Coronavirus-induced myocarditis: a meta-summary of cases. Heart Lung. 2020;49:681–685. doi:10.1016/j.hrtlng.2020.08.013
   PubMed Web of Science ®Google Scholar
• Khatri A, Wallach F. Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: a case report and literature review. Heart Lung. 2020;49(6):858–863. doi:10.1016/j.hrtlng.2020.06.003
   Web of Science ®Google Scholar
• Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: possible mechanisms. Life Sci. 2020;253:117723. doi:10.1016/j.lfs.2020.117723
   PubMed Web of Science ®Google Scholar
• Tam C, Cheung K, Lam S, et al. Impact of coronavirus disease 2019 (COVID‐19) outbreak on outcome of myocardial infarction in Hong Kong, China. Catheter Cardiovasc Interv. 2020;97:E194–E197. doi:10.1002/ccd.28943
   Web of Science ®Google Scholar
• Agdamag A, Edmiston J, Charpentier V, et al. Update on COVID-19 myocarditis. Medicina. 2020;56(12):678. doi:10.3390/medicina56120678
   Web of Science ®Google Scholar
• Lorente-Ros A, Ruiz JM, Rincón LM, et al. Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients. Cardiol J. 2020. doi:10.5603/CJ.a2020.0089
   Web of Science ®Google Scholar
• Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19–related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020;17:1463–1471. doi:10.1016/j.hrthm.2020.05.001
   PubMed Web of Science ®Google Scholar
• Ayad S, Shenouda R, Henein M. The impact of COVID-19 on in-hospital outcomes of ST-Segment elevation myocardial infarction patients. J Clin Med. 2021;10(2):278. doi:10.3390/jcm10020278
   Web of Science ®Google Scholar
• Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID‐19 cardiogenic shock. Eur J Heart Fail. 2020;22:911–915. doi:10.1002/ejhf.1828
   PubMed Web of Science ®Google Scholar
• Efros O, Barda N, Meisel E, et al. Myocardial injury in hospitalized patients with COVID-19 infection—risk factors and outcomes. PLoS One. 2021;16(2):e0247800. doi:10.1371/journal.pone.0247800
   Web of Science ®Google Scholar
• Lala A, Johnson K, Russak A, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 Infection. medRxiv. 2020;45:12–67.
   Google Scholar
• Toscano O, Cosentino N, Campodonico J, Bartorelli AL, Marenzi G. Acute myocardial infarction during the COVID-19 pandemic: an update on clinical characteristics and outcomes. Front cardiovasc med. 2021;8. doi:10.3389/fcvm.2021.648290
   Web of Science ®Google Scholar
• Deng Q, Hu B, Zhang Y, et al. Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116–121. doi:10.1016/j.ijcard.2020.03.087
   PubMed Web of Science ®Google Scholar
• Haiduc AA, Ogunjimi M, Shammus R, et al. COVID-19 and congenital heart disease: an insight of pathophysiology and associated risks. Cardiol Young. 2020;17:1–8.
   Google Scholar
• Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a Modelling Study. Lancet. 2020;395(10225):689–697. doi:10.1016/S0140-6736(20)30260-9
   PubMed Web of Science ®Google Scholar
• Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi:10.1016/S0140-6736(20)30154-9
   PubMed Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Radke R, Frenzel T, Baumgartner H, Diller G. Adult congenital heart disease and the COVID-19 pandemic. Heart. 2020;106:1302–1309. doi:10.1136/heartjnl-2020-317258
   Web of Science ®Google Scholar
• Diller G, Gatzoulis M, Broberg C, et al. Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease. Eur Heart J. 2020;24:654–658.
   Google Scholar
• Alsaied T, Aboulhosn J, Cotts T, et al. Coronavirus disease 2019 (COVID‐19) pandemic implications in pediatric and adult congenital heart disease. J Am Heart Assoc. 2020;9. doi:10.1161/JAHA.120.017224
   Web of Science ®Google Scholar
• Rey JR, Caro-Codón J, Rosillo S, et al. Heart failure in Covid‐19 patients: prevalence, incidence and prognostic implications. Eur J Heart Fail. 2020;22:2205–2215. doi:10.1002/ejhf.1990
   PubMed Web of Science ®Google Scholar
• Tomasoni D, Italia L, Adamo M, et al. COVID- 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease. Eur J Heart Fail. 2020;22:957–966. doi:10.1002/ejhf.1871
   PubMed Web of Science ®Google Scholar
• Ullah W, Saeed R, Sarwar U, Patel RV, Fischman D. COVID-19 complicated by acute pulmonary embolism and right-sided heart failure. Jacc Case Rep. 2020;2:1379–1382. doi:10.1016/j.jaccas.2020.04.008
   Google Scholar
• Bader F, Manla Y, Atallah B, Starling R. Heart failure and COVID-19. Heart Fail Rev. 2020;1–10. doi:10.1007/s10741-019-09838-6
   Web of Science ®Google Scholar
• Sankaranarayanan R, Hartshorne-Evans N, Redmond-Lyon S, et al. The Impact of COVID-19 on the management of heart failure -A United Kingdom Patient Questionnaire Study. medRxiv. 2020;45:678.
   Google Scholar
• Bertagnin E, Greco A, Bottaro G, et al. Remote monitoring for heart failure management during COVID-19 pandemic. Int J Cardiol. 2021;32. doi:10.1016/j.ijcha.2021.100724
   Web of Science ®Google Scholar
• Kałużna-Oleksy M, Gackowski A, Jankowska EA, et al. The patient with heart failure in the face of the coronavirus disease 2019 pandemic. Kardiologia Polska. 2020;78:618–631.
   Web of Science ®Google Scholar
• Ata F, Montoro-López M, Awouda S, Elsukkar A, Badr A, Patel A. COVID-19 and heart failure: the big challenge. heart views. Off J Gulf Heart Assoc. 2020;21:187–192.
   Google Scholar
• Chatrath N, Kaza N, Pabari PA, et al. The effect of concomitant COVID‐19 infection on outcomes in patients hospitalized with heart failure. ESC Heart Failure. 2020;7:4443–4447. doi:10.1002/ehf2.13059
   Web of Science ®Google Scholar
• Bhatt A, Jering KS, Vaduganathan M, et al. Clinical outcomes in patients with heart failure hospitalized with COVID-19. JACC Heart Fail. 2021;9:65–73. doi:10.1016/j.jchf.2020.11.003
   Web of Science ®Google Scholar
• Kerr B, Pharithi R, Barrett M, et al. Changing to remote management of a community heart failure population during COVID-19 – clinician and patient perspectives’. International Journal of Cardiology.. Heart Vasc. 2020;31:456.
   Web of Science ®Google Scholar
• Orso F, Migliorini M, Herbst A, et al. Protocol for telehealth evaluation and follow-up of patients with chronic heart failure during the COVID-19 pandemic. J Am Med Dir Assoc. 2020;21:1803–1807. doi:10.1016/j.jamda.2020.10.017
   PubMed Web of Science ®Google Scholar
• Reza N, DeFilippis E, Jessup M. Secondary impact of the COVID-19 pandemic on patients with heart failure. Circulation. 2020;34:534.
   Google Scholar
• Bakhsh A, Alqaseer M, Alayoubi F, et al. Health care delivery for heart failure patients during the COVID-19 pandemic; A consensus of The Saudi Heart Failure Working Group (Saudi-HF). J Saudi Heart Assoc. 2020;32:20–23. doi:10.37616/2212-5043.1073
   Web of Science ®Google Scholar
• Khan E. Heart failure and COVID-19: synergism of two inflammatory conditions? Br J Community Nurs. 2021;26(1):18–25. doi:10.12968/bjcn.2021.26.1.18
   Google Scholar
• DeFilippis E, Reza N, Donald E, Givertz M, Lindenfeld J, Jessup M. Considerations for heart failure care during the COVID-19 pandemic. JACC Heart Fail. 2020;8:681–691. doi:10.1016/j.jchf.2020.05.006
   Web of Science ®Google Scholar
• Wang Y, Wang Z, Tse G, et al. Cardiac arrhythmias in patients with COVID‐19. J Arrhythmia. 2020;36:827–836. doi:10.1002/joa3.12405
   PubMed Web of Science ®Google Scholar
• Malaty M, Kayes T, Amarasekera A, Kodsi M, Macintyre C, Tan T. Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: a systematic review. Eur J Clin Invest. 2020;51. doi:10.1111/eci.13428
   Web of Science ®Google Scholar
• Nalugo M, Schulte L, Masood M, Zayed M. Microvascular angiopathic consequences of COVID-19. Front Cardiovasc Med. 2020;8:26.
   Web of Science ®Google Scholar
• Sattar Y, Ullah W, Rauf H, et al. COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management. Int J Cardiol. 2020;29:23.
   Google Scholar
• Krittanawong C, Kumar A, Hahn J, et al. Cardiovascular risk and complications associated with COVID-19. Am J Cardiovasc Dis. 2020;10(4):479–489.
   PubMed Web of Science ®Google Scholar
• Samidurai A, Das A. Cardiovascular complications associated with COVID-19 and potential therapeutic strategies. Int J Mol Sci. 2020;21:6790. doi:10.3390/ijms21186790
   Web of Science ®Google Scholar
• Matsushita K, Marchandot B, Jesel L, Ohlmann P, Morel O. Impact of COVID-19 on the cardiovascular system: a review. J Clin Med. 2020;9:1407. doi:10.3390/jcm9051407
   Web of Science ®Google Scholar
• Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am College Cardiol. 2020;75:2352–2371.
   PubMed Web of Science ®Google Scholar
• Dhakal B, Sweitzer N, Indik J, Acharya D, William P. SARS-CoV-2 infection and cardiovascular disease: COVID-19 heart. Heart Lung Circ. 2020;29:973–987. doi:10.1016/j.hlc.2020.05.101
   PubMed Web of Science ®Google Scholar
• Pérez-Bermejo JA, Kang S, Rockwood SJ, et al. SARS-CoV-2 infection of human iPSC–derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19. Sci Transl Med. 2021;13. doi:10.1126/scitranslmed.abf7872
   Web of Science ®Google Scholar
• Zhou M, Wong C, Un K, et al. Cardiovascular sequalae in uncomplicated COVID-19 survivors. PLoS One. 2021;16(2):e0246732. doi:10.1371/journal.pone.0246732
   PubMed Web of Science ®Google Scholar
• Li C, Jiang J, Wang F, et al. Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients. J Mol Cell Cardiol. 2020;147:74–87. doi:10.1016/j.yjmcc.2020.08.008
   Web of Science ®Google Scholar
• Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1–8. doi:10.1001/jamacardio.2020.1017
   Web of Science ®Google Scholar
• Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA cardiol. 2020;5:802. doi:10.1001/jamacardio.2020.0950
   PubMed Web of Science ®Google Scholar
• Cao J, Zheng Y, Luo Z, et al. Myocardial injury and COVID-19: serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease. Theranostics. 2020;10:9663–9673. doi:10.7150/thno.47980
   PubMed Web of Science ®Google Scholar
• Si D, Du B, Ni L, et al. Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury. Can Med Assoc J. 2020;192:E791- E798. doi:10.1503/cmaj.200879
   PubMed Web of Science ®Google Scholar
• Bugger H, Gollmer J, Pregartner G, et al. Complications and mortality of cardiovascular emergency admissions during COVID-19 associated restrictive measures. PLoS One. 2020;15:e0239801. doi:10.1371/journal.pone.0239801
   Web of Science ®Google Scholar
• Hanfi Y, Alasnag M, Alshehri H, et al. Non-invasive cardiac imaging during the coronavirus disease 2019 (COVID-19) pandemic: a statement from the cardiac imaging working group of the Saudi Heart Association. J Saudi Heart Assoc. 2020;32:6–10. doi:10.37616/2212-5043.1029
   Web of Science ®Google Scholar
• Centurión O, Scavenius KE, García LB, Torales J, Miño L. Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19. Crit Pathw Cardiol. 2020;34:456.
   Google Scholar
• Shirazi S, Mami S, Mohtadi N, et al. Sudden cardiac death in COVID-19 patients, a report of three cases. Future Cardiol. 2020;17:113–118. doi:10.2217/fca-2020-0082
   Google Scholar
• Mahenthiran AK, Mahenthiran A, Mahenthiran J. Cardiovascular system and COVID-19: manifestations and therapeutics. Rev Cardiovasc Med. 2020;21(3):399–409. doi:10.31083/j.rcm.2020.03.124
   Web of Science ®Google Scholar
• Liao C, Chang W, Yu W, Toh H. Management of acute cardiovascular events in patients with COVID-19. Rev Cardiovasc Med. 2020;21(4):577–581.
   Web of Science ®Google Scholar
• Chatzis D, Magounaki KT, Pantazopoulos I, Johnson E, Tsioufis K. COVID-19 pandemic and cardiovascular disease: where do we stand? Minerva Cardioangiol. 2020;68. doi:10.23736/S0026-4725.20.05298-6
   Web of Science ®Google Scholar
• Wang B. Susceptibility and prognosis of COVID-19 patients with cardiovascular disease. Open Heart. 2020;7:e001310. doi:10.1136/openhrt-2020-001310
   Web of Science ®Google Scholar
• Nejadghaderi SA, Heidari A, Shakerian N, Saghazadeh A, Rezaei N. Cardiovascular system is at higher risk of affecting by COVID-19. Acta Bio Medica. 2020;91:e2020018- e2020018.
   Google Scholar
• Massoomi MR, Anderson RD, Ahmed MM, et al. Cardiovascular considerations for the internist and hospitalist in the COVID-19 era. Am J Med. 2020;133:1254–1261. doi:10.1016/j.amjmed.2020.06.005
   Web of Science ®Google Scholar
• Larson A, Savastano L, Kadirvel R, Kallmes D, Hassan A, Brinjikji W. Coronavirus disease 2019 and the cerebrovascular‐cardiovascular systems: what Do We Know So Far? J Am Heart Assoc. 2020;9. doi:10.1161/JAHA.120.016793
   Web of Science ®Google Scholar
• Du H, Wang D, Chen C. The potential effects of DPP‐4 inhibitors on cardiovascular system in COVID‐19 patients. J Cell Mol Med. 2020;24:10274–10278. doi:10.1111/jcmm.15674
   Web of Science ®Google Scholar
• Rastogi A, Tewari P. Covid 19 and its cardiovascular effects. Ann Card Anaesth. 2020;23:401–408. doi:10.4103/aca.aca_237_20
   Web of Science ®Google Scholar
• Gerc V, Masic I, Salihefendic N, Zildžić M. Cardiovascular diseases (CVDs) in COVID-19 pandemic era. Mater Sociomed. 2020;32:158–164. doi:10.5455/msm.2020.32.158-164
   Google Scholar
• Bandyopadhyay D, Akhtar T, Hajra A, et al. COVID-19 pandemic: cardiovascular complications and future implications. Am J Cardiovasc Drugs. 2020;43:1–14.
   Google Scholar
• Sabatino J, Rosa SD, Salvo GD, Indolfi C. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis. PLoS One. 2020;15:e23.
   Web of Science ®Google Scholar
• Mattioli A, Puviani MB, Nasi M, Farinetti A. COVID-19 pandemic: the effects of quarantine on cardiovascular risk. Eur J Clin Nutr. 2020;3:1–4.
   Google Scholar
• Li G, Saguner A, An J, et al. Cardiovascular disease during the COVID-19 pandemic: think ahead, protect hearts, reduce mortality. Cardiol J. 2020. doi:10.5603/CJ.a2020.0101
   Web of Science ®Google Scholar
• Dixon D, Tassell BV, Vecchié A, et al. Cardiovascular considerations in treating patients with coronavirus disease 2019 (COVID-19). J Cardiovasc Pharmacol. 2020;75:359–367. doi:10.1097/FJC.0000000000000836
   PubMed Web of Science ®Google Scholar
• Medzikovic L, Cunningham C, Li M, et al. Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. J Mol Cell Cardiol. 2020;148:25–33. doi:10.1016/j.yjmcc.2020.08.007
   Web of Science ®Google Scholar
• Yu J, Wu B, Yang J, Lei X, Shen W. Cardio-cerebrovascular disease is associated with severity and mortality of COVID-19: a systematic review and meta-analysis. Biol Res Nurs. 2020;23:258–269. doi:10.1177/1099800420951984
   Web of Science ®Google Scholar
• Kow CS, Zaidi S, Hasan S. Cardiovascular disease and use of renin-angiotensin system inhibitors in COVID-19. Am J Cardiovasc Drugs. 2020;45:1–5.
   Google Scholar
• Santoso A, Pranata R, Wibowo A, Al-Farabi MJ, Huang I, Antariksa B. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: a meta-analysis. Am J Emerg Med. 2020;43:546.
   Google Scholar
• Saleh SK, Oraii A, Soleimani A, et al. The association between cardiac injury and outcomes in hospitalized patients with COVID-19. Intern Emerg Med. 2020;4:1–10.
   Google Scholar
• Hasnie UA, Bhambhvani PG, Iskandrian A, Hage F. Prevalence of abnormal SPECT myocardial perfusion imaging during the COVID-19 pandemic. Eur J Nucl Med Mol Imaging. 2021;45:1–8.
   Google Scholar
• Kishor K, Marwah R, Anantharaj A, Kalra S. Cardiovigilance in COVID 19. JPMA. 2020;70(Suppl3):S77–S80.
   Google Scholar
• Leon-Constantin M, Maștaleru A, Abdulan I, Zota M, Cojocariu S, Mitu F. Cardiac complications in patients infected with COVID-19. Internal Med. 2020;17:55–62. doi:10.2478/inmed-2020-0134
   Google Scholar
• Wang H, Li R, Zhou Z, et al. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2021;23:44.
   Web of Science ®Google Scholar
• Michieli LD, Babuin L, Vigolo S, et al. Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): the Padova experience. Clin Biochem. 2021;90:8–14. doi:10.1016/j.clinbiochem.2021.01.006
   Web of Science ®Google Scholar
• Metkus T, Sokoll L, Barth AS, et al. Myocardial injury in severe COVID-19 compared with non–COVID-19 acute respiratory distress syndrome. Circulation. 2020;143:553–565. doi:10.1161/CIRCULATIONAHA.120.050543
   Web of Science ®Google Scholar
• Maier SR, Rodrigues J, Sudré MR, Dessotte C. Cardiac complications in patients with COVID-19: an integrative literature review. Aquichan. 2020;20:2043. doi:10.5294/aqui.2020.20.4.3
   Google Scholar
• Yasmin F, Shujauddin S, Naeem A, et al. Exploring the impact of the COVID-19 pandemic on provision of cardiology services: a scoping review. Rev Cardiovasc Med. 2021;22(1):83–95. doi:10.31083/j.rcm.2021.01.241
   Web of Science ®Google Scholar
• Heuvel FM, Vos JL, Koop Y, et al. Cardiac function in relation to myocardial injury in hospitalised patients with COVID-19. Neth Heart J. 2020;28:410–417. doi:10.1007/s12471-020-01458-2
   Web of Science ®Google Scholar
• Kaya Y, Bostan S, Düğeroğlu H, Özbilen M, Keskin H. The effect of COVID-19 pandemic on the anxiety levels of internal medicine physicians and practice of internal medicine clinics. J Int Health Sci Manage. 2020. doi:10.48121/jihsam.772710
   Google Scholar
• Bakhshi H, Gattani R, Ekanem E, et al. Ventricular septal rupture and cardiogenic shock complicating STEMI during COVID-19 pandemic: an old foe re-emerges. Heart Lung. 2020;50:292–295. doi:10.1016/j.hrtlng.2020.12.013
   Web of Science ®Google Scholar
• Ferrari R, Pasquale GD, Rapezzi C. 2019 CORONAVIRUS: what are the implications for cardiology? Eur J Prev Cardiol. 2020;27:793–796. doi:10.1177/2047487320918102
   Web of Science ®Google Scholar
• Grzegorowska O, Lorkowski J. Possible correlations between atherosclerosis, acute coronary syndromes and COVID-19. J Clin Med. 2020;9:3746. doi:10.3390/jcm9113746
   PubMed Web of Science ®Google Scholar
• Dash S, Dhiman A, Pandey P, Kumar A. Late presentation of acute coronary syndrome during COVID-19. Med J Dr D Y Patil Vidyapeeth. 2020;13:269–273. doi:10.4103/mjdrdypu.mjdrdypu_209_20
   Google Scholar
• Hatami F, Valizadeh N, Ramandi M. Emerging mechanisms for the new coronavirus-related myocardial injury and ischemia: a review of the literature. Anatolian J Cardiol. 2020;24:7–12. doi:10.14744/AnatolJCardiol.2020.68166
   Web of Science ®Google Scholar
• Zakeri AS, Jadhav A, Sullenger B, Nimjee S. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist. J Neurointerv Surg. 2020;13:202–206. doi:10.1136/neurintsurg-2020-016794
   Web of Science ®Google Scholar
• Alonso M, Mata-Forte T, García-León N, et al. Incidence, characteristics, laboratory findings and outcomes in acro-ischemia in COVID-19 patients. Vasc Health Risk Manag. 2020;16:467–478. doi:10.2147/VHRM.S276530
   PubMed Web of Science ®Google Scholar